Atlantic Antibodies was acquired in 1999 by STRATEGIC DIAGNOSTICS INC. With the acquisitions of HTI BioProducts, Inc. and certain assets of Atlantic Antibodies, Strategic BioSolutions (SBS), (NASDAQ: SDIX) was formed. The firm has since become one of the largest producers of antibodies in the United States. The mission of Strategic BioSolutions is to supply monoclonal and polyclonal antibodies, immunochemical reagents and related services to medical diagnostic and pharmaceutical companies, as well as research institutions.